Publications by authors named "Lidia Robert"

Claim this Profile
D
Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes.
Lidia Robert, Christina Harview, Ryan Emerson, Xiaoyan Wang, Stephen Mok

Oncoimmunology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line.
Yapeng Su, Melissa E Ko, Hanjun Cheng, Ronghui Zhu, Min Xue, Lidia Robert

Nat Commun· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance.
Yapeng Su, Marcus Bintz, Yezi Yang, Lidia Robert, Alphonsus H C Ng

PLoS Comput Biol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy Resistance by Inflammation-Induced Dedifferentiation.
Arnav Mehta, Yeon Joo Kim, Lidia Robert, Jennifer Tsoi, Begoña Comin-Anduix

Cancer Discov· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress.
Jennifer Tsoi, Lidia Robert, Kim Paraiso, Carlos Galvan, Katherine M Sheu

Cancer Cell· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors.
Stergios J Moschos, Ryan J Sullivan, Wen-Jen Hwu, Ramesh K Ramanathan, Alex A Adjei, W Robert Bishop, Lidia Robert

JCI Insight· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance.
Yapeng Su, Wei Wei, Lidia Robert, Min Xue, Jennifer Tsoi

Proc Natl Acad Sci U S A· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor.
Sean Caenepeel, Keegan Cooke, Sarah Wadsworth, Guo Huang, Lidia Robert

Oncotarget· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells.
Blanca Homet Moreno, Jesse M Zaretsky, Angel Garcia-Diaz, Jennifer Tsoi, Giulia Parisi, Lidia Robert

Cancer Immunol Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2?
Lidia Robert, Antoni Ribas, Siwen Hu-Lieskovan

Semin Immunol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma.
Deborah J L Wong, Lidia Robert, Mohammad S Atefi, Amanda Lassen, Geetha Avarappatt

Mol Cancer· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 therapy in melanoma.
Blanca Homet Moreno, Giulia Parisi, Lidia Robert, Antoni Ribas

Semin Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.
Siwen Hu-Lieskovan, Stephen Mok, Blanca Homet Moreno, Jennifer Tsoi, Lidia Robert

Sci Transl Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells.
Diego Ploper, Vincent F Taelman, Lidia Robert, Brian S Perez, Björn Titz, Edward M De Robertis

Proc Natl Acad Sci U S A· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Judith Müller, Oscar Krijgsman, Jennifer Tsoi, Lidia Robert, Willy Hugo

Nat Commun· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Paul C Tumeh, Christina L Harview, Jennifer H Yearley, I Peter Shintaku, Emma J M Taylor, Lidia Robert, Robert H Pierce, Caroline Robert

Nature· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanoma.
Deborah J L Wong, Lidia Robert, Mohammad S Atefi, Amanda Lassen, Geetha Avarappatt

Mol Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma.
Mohammad Atefi, Earl Avramis, Amanda Lassen, Deborah J L Wong, Lidia Robert

Clin Cancer Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges.
Siwen Hu-Lieskovan, Lidia Robert, Blanca Homet Moreno, Antoni Ribas

J Clin Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA4 blockade broadens the peripheral T-cell receptor repertoire.
Lidia Robert, Jennifer Tsoi, Xiaoyan Wang, Ryan Emerson, Blanca Homet

Clin Cancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma.
Amanda Lassen, Mohammad Atefi, Lidia Robert, Deborah Jl Wong, Michael Cerniglia

Mol Cancer· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.
Stephen Mok, Richard C Koya, Christopher Tsui, Jingying Xu, Lídia Robert

Cancer Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lytic lesions in a patient with past history of renal cancer.
Ana Sebio, Lidia Robert, Diana Ovejero, Paola Murata, Ivana Sullivan

Arch Esp Urol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.
Fei Su, Amaya Viros, Carla Milagre, Kerstin Trunzer, Gideon Bollag, Robert Hayward, Lídia Robert

N Engl J Med· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
Jorge Aparicio, Pablo Maroto, Xavier García del Muro, Josep Gumà, Alfonso Sánchez-Muñoz, Lidia Robert

J Clin Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis